Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are enrolled in or covered by a social security scheme
- People who have signed a written consent form agreeing to take part
- People who have been diagnosed with multiple myeloma for the first time (meaning it has not been treated before) and whose condition requires treatment
Who may not be able to join:
- People who are pregnant
- People who are under legal guardianship, who are in custody, or who have any condition that affects their ability to understand and sign a consent form
- People who do not wish to take part in the trial
- People whose ability to attend follow-up appointments is limited, or whose life expectancy is less than 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emilie Chalayer, MD, CHU de Saint-Etienne
Phone: 04 77 91 70 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Level of thrombin generation in newly diagnosed and untreated MM; Level of factor VIII in newly diagnosed and untreated MM; Level of D-Dimers in newly diagnosed and untreated MM; Level of pro-coagulant phospholipids in newly diagnosed and untreated MM
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.